503 related articles for article (PubMed ID: 22211842)
1. Transforming growth factor-β/Smad signalling in diabetic nephropathy.
Lan HY
Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):731-8. PubMed ID: 22211842
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta and Smad signalling in kidney diseases.
Wang W; Koka V; Lan HY
Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease.
Li JH; Huang XR; Zhu HJ; Oldfield M; Cooper M; Truong LD; Johnson RJ; Lan HY
FASEB J; 2004 Jan; 18(1):176-8. PubMed ID: 12709399
[TBL] [Abstract][Full Text] [Related]
4. Role of the TGF-β/BMP-7/Smad pathways in renal diseases.
Meng XM; Chung AC; Lan HY
Clin Sci (Lond); 2013 Feb; 124(4):243-54. PubMed ID: 23126427
[TBL] [Abstract][Full Text] [Related]
5. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
[TBL] [Abstract][Full Text] [Related]
6. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
[TBL] [Abstract][Full Text] [Related]
7. TGF-β/Smad signaling in kidney disease.
Lan HY; Chung AC
Semin Nephrol; 2012 May; 32(3):236-43. PubMed ID: 22835454
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
Yang F; Chung AC; Huang XR; Lan HY
Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-β and Smads.
Lan HY; Chung ACK
Contrib Nephrol; 2011; 170():75-82. PubMed ID: 21659760
[TBL] [Abstract][Full Text] [Related]
10. Diverse roles of TGF-β/Smads in renal fibrosis and inflammation.
Lan HY
Int J Biol Sci; 2011; 7(7):1056-67. PubMed ID: 21927575
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II activates connective tissue growth factor and induces extracellular matrix changes involving Smad/activation and p38 mitogen-activated protein kinase signalling pathways in human dermal fibroblasts.
Zhang GY; Li X; Yi CG; Pan H; He GD; Yu Q; Jiang LF; Xu WH; Li ZJ; Ding J; Lin DS; Gao WY
Exp Dermatol; 2009 Nov; 18(11):947-53. PubMed ID: 19397700
[TBL] [Abstract][Full Text] [Related]
12. Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation.
Gu L; Zhu YJ; Yang X; Guo ZJ; Xu WB; Tian XL
Acta Pharmacol Sin; 2007 Mar; 28(3):382-91. PubMed ID: 17303001
[TBL] [Abstract][Full Text] [Related]
13. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
15. miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.
McClelland AD; Herman-Edelstein M; Komers R; Jha JC; Winbanks CE; Hagiwara S; Gregorevic P; Kantharidis P; Cooper ME
Clin Sci (Lond); 2015 Dec; 129(12):1237-49. PubMed ID: 26415649
[TBL] [Abstract][Full Text] [Related]
16. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide regulates transforming growth factor-beta signaling in endothelial cells.
Saura M; Zaragoza C; Herranz B; Griera M; Diez-Marqués L; Rodriguez-Puyol D; Rodriguez-Puyol M
Circ Res; 2005 Nov; 97(11):1115-23. PubMed ID: 16239590
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling.
Chung AC; Zhang H; Kong YZ; Tan JJ; Huang XR; Kopp JB; Lan HY
J Am Soc Nephrol; 2010 Feb; 21(2):249-60. PubMed ID: 19959709
[TBL] [Abstract][Full Text] [Related]
19. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells.
Leivonen SK; Ala-Aho R; Koli K; Grénman R; Peltonen J; Kähäri VM
Oncogene; 2006 Apr; 25(18):2588-600. PubMed ID: 16407850
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts.
He S; Liu X; Yang Y; Huang W; Xu S; Yang S; Zhang X; Roberts MS
Br J Dermatol; 2010 Mar; 162(3):538-46. PubMed ID: 19772524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
